Login
$ANTX
$4.47 -$0.08 (1.76%) Live

$ANTX 3 SEC Filings

Filed On Filing
27 Aug 2026 Form 3: Trenor Cameron C. Iii, Chief Medical Officer

No securities owned

03 Feb 2026 Form 3: Williams Sarah Joanne, Principal Accounting Officer

Holds 18,800 shares of Common Stock

05 Nov 2024 Form 3: Prior Stephen David, Chief Strategy Officer

Holds 25,217 shares of Common Stock

12 Aug 2024 Form 3: Leonard Braden Michael, 10% owner

Holds 4,249,432 shares of Common Stock

05 Oct 2022 Form 3: Eizen Joshua M, See Remarks

No securities owned

09 May 2022 Form 3: FitzPatrick Margaret M, Director

No securities owned

24 Mar 2022 Form 3: Krause Kevin Michael, Chief Strategy Officer
24 Mar 2022 Form 3: Spigelman Melvin K, Director
24 Mar 2022 Form 3: Martin Patricia A., Director
24 Mar 2022 Form 3: Zakrzewski Joseph S, Director

Holds 505,880 shares of Common Stock

24 Mar 2022 Form 3: Eckburg Paul, Chief Medical Officer

Holds 18,289 shares of Common

24 Mar 2022 Form 3: Aziz Kabeer, Director
24 Mar 2022 Form 3: Nazak Michael Adrian, Chief Accounting Officer
24 Mar 2022 Form 3: Marks Gilbert Lynn, Director

Holds 22,830 shares of Common Stock

24 Mar 2022 Form 3: Readnour Robin Shane, Director
24 Mar 2022 Form 3: Day Lucy, Chief Financial Officer
24 Mar 2022 Form 3: Easom Eric, Director

Holds 1,099,997 shares of Common Stock

24 Mar 2022 Form 3: Chanda Sanjay, Chief Development Officer
24 Mar 2022 Form 3: Adjuvant Global Health Technology Fund, L.p., 10% owner and 1 other
24 Mar 2022 Form 3: Wong Stephanie, Director

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support